Literature DB >> 20660413

Aprepitant for erlotinib-induced pruritus.

Bruno Vincenzi, Giuseppe Tonini, Daniele Santini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20660413     DOI： 10.1056/NEJMc1003937

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  20 in total

Review 1.  Management of cutaneous adverse events induced by anti-EGFR (epidermal growth factor receptor): a French interdisciplinary therapeutic algorithm.

Authors:  Z Reguiai; J B Bachet; C Bachmeyer; L Peuvrel; M Beylot-Barry; M Bezier; E Boucher; C Chevelle; P Colin; R Guimbaud; L Mineur; M A Richard; P Artru; P Dufour; J M Gornet; E Samalin; R J Bensadoun; M Ychou; T André; B Dreno; O Bouché
Journal:  Support Care Cancer       Date:  2012-04-27       Impact factor: 3.603

Review 2.  Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?

Authors:  Nicholas K Mollanazar; Peter K Smith; Gil Yosipovitch
Journal:  Clin Rev Allergy Immunol       Date:  2016-12       Impact factor: 8.667

Review 3.  Molecular and cellular mechanisms that initiate pain and itch.

Authors:  Jialie Luo; Jing Feng; Shenbin Liu; Edgar T Walters; Hongzhen Hu
Journal:  Cell Mol Life Sci       Date:  2015-04-18       Impact factor: 9.261

Review 4.  Psychoneuroimmunology of psychological stress and atopic dermatitis: pathophysiologic and therapeutic updates.

Authors:  Andrea L Suárez; Jamison D Feramisco; John Koo; Martin Steinhoff
Journal:  Acta Derm Venereol       Date:  2012-01       Impact factor: 4.437

Review 5.  Targeted treatment of pruritus: a look into the future.

Authors:  H L Tey; G Yosipovitch
Journal:  Br J Dermatol       Date:  2011-05-30       Impact factor: 9.302

6.  TRPA1 controls inflammation and pruritogen responses in allergic contact dermatitis.

Authors:  Boyi Liu; Jasmine Escalera; Shrilatha Balakrishna; Lu Fan; Ana I Caceres; Eve Robinson; Aiwei Sui; M Craig McKay; M Allen McAlexander; Christina A Herrick; Sven E Jordt
Journal:  FASEB J       Date:  2013-05-30       Impact factor: 5.191

7.  Neurokinin 1 Receptor Antagonists for Pruritus.

Authors:  Majid Alam; Joerg Buddenkotte; Fareed Ahmad; Martin Steinhoff
Journal:  Drugs       Date:  2021-03-06       Impact factor: 9.546

Review 8.  Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities.

Authors:  Mario E Lacouture; Milan J Anadkat; René-Jean Bensadoun; Jane Bryce; Alexandre Chan; Joel B Epstein; Beth Eaby-Sandy; Barbara A Murphy
Journal:  Support Care Cancer       Date:  2011-06-01       Impact factor: 3.603

9.  Characterization and management of ERK inhibitor associated dermatologic adverse events: analysis from a nonrandomized trial of ulixertinib for advanced cancers.

Authors:  J Wu; D Liu; M Offin; B T Li; M E Lacouture; C Lezcano; J M Torrisi; S Brownstein; D M Hyman; M M Gounder; W Abida; A Drilon; J J Harding; R J Sullivan; F Janku; D Welsch; M Varterasian; A Groover
Journal:  Invest New Drugs       Date:  2021-01-03       Impact factor: 3.651

10.  Paraneoplastic pruritus presenting with Hodgkin's lymphoma: a case report.

Authors:  Jose Javier Arenas Villafranca; Marga Garrido Siles; María Casanova; Begoña Tortajada Goitia; Antonio Rueda Domínguez
Journal:  J Med Case Rep       Date:  2014-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.